The Regenerative Health Association Podcast Feature
Multiple sclerosis (MS) is a devastating autoimmune disease that affects millions worldwide, particularly in regions far from the equator, such as the United States, Canada, and Northern and Western Europe. With a prevalence as high as 1 in 400 people in some areas and a disproportionate impact on women, MS remains a major challenge for patients, clinicians, and researchers alike. But recent scientific breakthroughs are transforming our understanding of this complex disease and opening new avenues for effective therapies—especially for progressive forms of MS, which have long lacked viable treatments.
If you’re interested in the latest advances in MS research, we invite you to listen to our new podcast episode featuring a recent lecture from The Front Row at Scripps Research. This episode dives deep into the molecular underpinnings of MS, the pivotal role of academic science, and the promise of regenerative medicine. Scripps Research chemistry professor Luke Lairson discussed his research on the body’s natural repair pathways—specifically those that activate endogenous stem cells to restore myelin.
Topics covered include:
- Understanding MS: The Cellular Battlefield
- Breakthroughs in Therapy: From Immune Modulation to B Cell Depletion
- The EBV Connection: A Viral Trigger for Autoimmunity
- The Unmet Need: Regeneration and Remyelination
- Innovative Approaches: Drug Discovery and Combination Therapies
- The Challenge of Aging: Why Remyelination Fails
Ready to learn more?
Tune in to this edition of The Regenerative Health Podcast episode for an in-depth conversation about these scientific advances, the stories behind the discoveries, and what the future holds for MS patients and regenerative medicine. Whether you’re a patient, caregiver, clinician, or scientist, this is a conversation you won’t want to miss.
